Bank Julius Baer & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28M | Buy |
260,823
+2,494
| +1% | +$268K | 0.08% | 123 |
|
|
2025
Q1 | $27.9M | Sell |
258,329
-33,097
| -11% | -$3.57M | 0.09% | 122 |
|
|
2024
Q4 | $27.6M | Buy |
291,426
+1,316
| +0.5% | +$124K | 0.09% | 130 |
|
|
2024
Q3 | $26.7M | Sell |
290,110
-11,090
| -4% | -$1.02M | 0.09% | 114 |
|
|
2024
Q2 | $24.6M | Sell |
301,200
-46,688
| -13% | -$3.81M | 0.09% | 109 |
|
|
2024
Q1 | $23.7M | Buy |
347,888
+15,285
| +5% | +$1.04M | 0.09% | 118 |
|
|
2023
Q4 | $19.2M | Buy |
332,603
+56,982
| +21% | +$3.29M | 0.08% | 139 |
|
|
2023
Q3 | $14.6M | Sell |
275,621
-14,306
| -5% | -$755K | 0.08% | 127 |
|
|
2023
Q2 | $15.7M | Sell |
289,927
-16,070
| -5% | -$869K | 0.09% | 128 |
|
|
2023
Q1 | $15.3M | Buy |
305,997
+18,007
| +6% | +$901K | 0.1% | 128 |
|
|
2022
Q4 | $13.3M | Buy |
287,990
+18,121
| +7% | +$839K | 0.09% | 132 |
|
|
2022
Q3 | $10.5M | Sell |
269,869
-3,787
| -1% | -$147K | 0.08% | 132 |
|
|
2022
Q2 | $10.2M | Buy |
273,656
+4,487
| +2% | +$167K | 0.07% | 135 |
|
|
2022
Q1 | $11.9M | Sell |
269,169
-15,010
| -5% | -$665K | 0.07% | 125 |
|
|
2021
Q4 | $12.1M | Sell |
284,179
-28,176
| -9% | -$1.2M | 0.06% | 143 |
|
|
2021
Q3 | $13.6M | Buy |
312,355
+25,545
| +9% | +$1.11M | 0.08% | 144 |
|
|
2021
Q2 | $12.3M | Buy |
286,810
+22,873
| +9% | +$978K | 0.08% | 154 |
|
|
2021
Q1 | $10.2M | Buy |
263,937
+67,303
| +34% | +$2.6M | 0.08% | 154 |
|
|
2020
Q4 | $7.07M | Buy |
196,634
+26,108
| +15% | +$939K | 0.06% | 163 |
|
|
2020
Q3 | $6.52M | Sell |
170,526
-88,045
| -34% | -$3.36M | 0.06% | 141 |
|
|
2020
Q2 | $9.08M | Buy |
+258,571
| New | +$9.08M | 0.1% | 117 |
|